Sök på Folkhälsomyndighetens webbplats

The high-containment laboratory at the Public Health Agency of Sweden in Solna is the only biosafety level 4 (BSL-4) facility in the Nordic countries and one of few in Europe. This brochure describes the facility and the services it provides.

Folkhälsomyndigheten utför diagnostik av unik natur, så kallad speciell diagnostik.

Sales of antibiotics and occurrence of antibiotic resistance in Sweden Swedres-Svarm 2018 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary

Biologiska agens klassificeras i fyra olika riskklasser (1 till 4). Kriterier för klassificering av biologiska agens finns beskrivna i tredje utgåvan av WHO:s Laboratory biosafety manual, i Europaparlamentets och rådets direktiv 2000/54/EG om skydd för arbetstagare mot risker vid exponering för

Biosäkerhet (biosafety) handlar om att förhindra oavsiktlig exponering för smittämnen eller oavsiktlig spridning till omgivning och miljö.

Med utgångspunkt från riskbedömningen vidtas de skyddsåtgärder som behövs för att arbetet ska kunna bedrivas utan att orsaka ohälsa eller olycksfall.

Sales of antibiotics and occurrence of antibiotic resistance in Sweden Swedres-Svarm 2017 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary

Sales of antibiotics and occurrence of antibiotic resistance in Sweden Swedres-Svarm 2020 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

This report describes the monitoring systems for influenza in use during the winter season of 2019–2020 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons. The report has been prepared for the World Health Organization (WHO)

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

This report summarizes the influenza A(H1N1)2009 pandemic in Sweden between April 24, 2009 and May 23, 2010. The report is based on data from the various surveillance systems used during the pandemic. The systems are presented in some detail to facilitate the reader’s understanding of the quality

2023–2024 Season This report describes epidemiological and virological surveillance results for the 2023-2024 influenza season in Sweden. Data are also compared to previous influenza seasons. Appendices 1, 2 and 3 contain phylogenetic trees for influenza A(H3N2), influenza A(H1N1)pdm09 and

This report describes the monitoring systems for influenza in use during the winter season of 2021–2022 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

This report describes the monitoring systems for influenza in use during the winter season of 2020–2021 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

En viktig princip inom bioriskhantering är användning av barriärer för att upprätthålla inneslutning ("containment") i ett kontrollerat område för det biologiska material som hanteras. I begreppet sekundära barriärer ryms hur anläggningen har utformats och konstruerats i syfte att förhindra

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

Skyddsåtgärder kan omfatta såväl organisatoriska åtgärder som särskild utformning av lokaler, tekniska anordningar och arbetsrutiner. En form av skyddsåtgärd är att välja lämplig skyddsnivå vid hantering av mikroorganismer och toxiner. Med skyddsnivå menas den grad av inneslutning som arbete i

Bioskydd (biosecurity) beskriver hur smittämnen och toxiner förvaras och hanteras på ett sådant sätt att de inte avsiktligt kan spridas och därigenom skada människan eller miljön.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.

Sales of antibiotics and occurrence of antibiotic resistance in Sweden Swedres-Svarm 2012 shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals. The report is a co-production between the Public Health Agency of Sweden the National Veterinary

Information om riskbedömning och hantering av biorisker, riskklasser för biologiska agens samt skyddsåtgärder för att inte orsaka ohälsa eller olycksfall.

The report shows statistics on antibiotic sales and antibiotic resistance in bacteria from both humans and animals.